Edition:
United States

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

31.66EUR
24 Mar 2017
Change (% chg)

€-0.07 (-0.22%)
Prev Close
€31.73
Open
€31.73
Day's High
€31.77
Day's Low
€31.42
Volume
353,358
Avg. Vol
464,392
52-wk High
€31.92
52-wk Low
€21.27

Latest Key Developments (Source: Significant Developments)

Recordati incorporates unit Recordati SA Chemical and Pharmaceutical Company
Thursday, 2 Mar 2017 04:17am EST 

Recordati Industria Chimica e Farmaceutica SpA :Said on Wednesday that it filed the project of incorporation of Luxembourg-based unit Recordati SA Chemical and Pharmaceutical Company.  Full Article

Recordati proposes dividend of EUR 0.70 per share
Wednesday, 1 Mar 2017 06:49am EST 

Recordati Industria Chimica e Farmaceutica SpA : Proposes dividend of 0.70 euro per share (0.60 euro per share in 2015), of which 0.35 euro per share already paid .Consolidated sales during the first two months of 2017 are particularly positive.  Full Article

Recordati signs license agreement with Meyer Hospital in Florence
Monday, 27 Feb 2017 09:49am EST 

Recordati Industria Chimica e Farmaceutica SpA : Signs exclusive license agreement with Meyer hospital in Florence . The agreement has as its object the know-how product of Meyer Hospital in Florence for the development of a treatment for pre-term infants suffering from retinopathy of prematurity .The agreement provides that the company will support for a period of three years other projects carried out by researchers at Meyer in the field of rare diseases.  Full Article

Recordati signs license agreement with the Meyer Hospital in Florence
Monday, 27 Feb 2017 03:25am EST 

Recordati Industria Chimica e Farmaceutica SpA : Signs an exclusive license agreement with the Meyer Hospital in Florence . Agreement covers the know-how of the Meyer Hospital for the development of a treatment for pre-term babies affected by retinopathy of prematurity . Treatment is currently being investigated in a phase II clinical trial by the Meyer Hospital .Recordati will complete the clinical development and the regulatory steps necessary to obtain the marketing approval for the drug.  Full Article

Italy's Recordati sees 2019 sales at around 1.45 bln euros
Thursday, 9 Feb 2017 06:04am EST 

Italy's Recordati:sees 2019 sales at around 1.45 billion euros.  Full Article

Recordati FY prelim. net income up 19.4 pct YoY at EUR 237.4 mln
Thursday, 9 Feb 2017 06:03am EST 

Recordati Industria Chimica e Farmaceutica SpA : FY preliminary net income, at 20.6 pct of sales, is 237.4 million euros ($253.69 million), an increase of 19.4 pct over that of 2015 .FY preliminary net revenue 1.15 billion euros, up 10.1 pct year on year.  Full Article

Recordati signs license agreement with Richter to commercialize cariprazine
Tuesday, 2 Aug 2016 02:00am EDT 

Recordati Industria Chimica e Farmaceutica SpA : Signs a license agreement with Gedeon Richter (Richter) to commercialize cariprazine in Western Europe and in Algeria, in Tunisia and in Turkey . The European Medicines Agency (EMA) started the evaluation of Richter's marketing authorization application for cariprazine, an atypical antipsychotic, for the treatment of schizophrenia in March . Recordati to make an upfront payment and further milestone payments depending on the progress of both the regulatory procedure and the product commercialization . Further sales-related royalties will become payable to Richter following the launch of the product .Richter to be responsible for conducting pediatric clinical studies according to the Pediatric Investigation Plan, as required by the European Medicines Agency's PDCO (Pediatric Committee) and it shall be co-financed with Recordati.  Full Article

Recordati H1 net profit jumps at EUR 122.7 mln
Thursday, 28 Jul 2016 06:05am EDT 

Recordati Industria Chimica E Farmaceutica SpA : H1 net profit 122.7 million euros ($136.07 million) versus 103.2 million euros a year ago, up 18.9 percent .H1 net revenues 587.9 million euros versus 539.1 million euros a year ago, up 9.1 percent.  Full Article

Recordati buys 100 pct stake in Swiss pharmaceutical company Pro Farma
Thursday, 14 Jul 2016 06:31am EDT 

Recordati Industria Chimica e Farmaceutica SpA : Announces acquisition of 100 percent of share capital of Pro Farma AG, a swiss pharmaceutical company .Value of transaction (enterprise value) is of 16 million Swiss francs ($16.31 million) and will be funded from existing liquidity.  Full Article

Italy's Recordati buys Italchimici in deal valued at 130 mln euros
Tuesday, 31 May 2016 10:05am EDT 

Italy's Recordati Industria Chimica E Farmaceutica says: has bought all of Italian pharmaceutical company Italchimici . deal valued at about 130 million euros .to be funded in cash.  Full Article

More From Around the Web